Michael Hart v. Publicis Touchpoint Solutions

Court of Appeals for the Sixth Circuit·Decided July 29, 2020·No. 19-2411·Unpublished

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 20a0440n.06

Case No. 19-2411

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT

FILED

Jul 29, 2020

MICHAEL HART, ) DEBORAH S. HUNT, Clerk )

Plaintiff-Appellant, ) ON APPEAL FROM THE ) UNITED STATES DISTRICT v. ) COURT FOR THE EASTERN ) DISTRICT OF MICHIGAN PUBLICIS TOUCHPOINT SOLUTIONS, INC., )

)

Defendant-Appellee. ) OPINION )

BEFORE: MOORE, CLAY, and McKEAGUE, Circuit Judges.

McKEAGUE, Circuit Judge. Michael Hart sued his previous employer, Publicis Touchpoint Solutions, claiming that it retaliated against him for refusing to violate the law, in violation of Michigan public policy. The district court granted summary judgment to Publicis, and Hart appealed. Because we find that there is no dispute of material fact, and Hart never refused to violate the law, we AFFIRM.

I

Michael Hart worked as a professional sales representative for Publicis Touchpoint Solutions from December 2012 to September 2016. Publicis had been hired by Pfizer to provide the sales force for two of Pfizer’s prescription drugs, Quillichew ER and Quillivant XR. And so, Hart was assigned a territory in Michigan and given a list of doctors’ offices to target for marketing

efforts. Every day, he was required to make eight sales calls. Three or four times per week, he hosted lunches for doctors, and frequently the doctors’ staff members, to discuss the drugs. And about once a year, he attended dinner programs where speakers educated medical staff in the audience about Quillichew or Quillivant.

A. Lansing Pediatrics Lunch In April 2014, Hart hosted a lunch at Lansing Pediatrics. When he called the office beforehand to confirm the lunch, he was directed to the office manager, Sherry Sheehan. Sheehan requested that he bring lunch for 60 people. She mentioned that any extra meals could go to the night staff or cleaning staff and that her daughter had a softball game that night. Hart balked. Only 30 people had attended his last lunch at Lansing Pediatrics in February. He was hesitant to provide so many extra meals. He believed providing them would violate the Physician Payments Sunshine Act (PPSA), and he told Sheehan so. She grew agitated with Hart, telling him not to question her.

According to Hart, he then spoke to his supervisor at Publicis, John Williams. He told Williams that Sheehan had requested 60 boxed lunches—which he believed violated the PPSA— and that things were “going south in a hurry.” Hart says he asked Williams if he could cancel, but Williams told him to go through with the lunch anyway.

Hart proceeded with the Lansing Pediatrics lunch, and things continued to go downhill.

Hart brought the 60 boxed lunches Sheehan requested, but he and Sheehan still scuffled about other aspects of the lunch, like the sign-in process. Moreover, only 32 people attended, which meant that Hart had brought 28 extra meals. And a few days later, Sheehan called Publicis to request that Hart no longer visit Lansing Pediatrics. She complained that Hart was “overly aggressive and verbally abusive,” and that he “inappropriately touched” a female employee at the lunch.

Williams (Hart’s supervisor) and Nancy McConville (Publicis’s senior human resources officer) called Hart to address the complaint. Hart defended himself, saying that Sheehan’s allegations were baseless. He believed Sheehan complained only because he resisted providing the extra lunches that she requested. McConville allegedly said that she accepted what Hart was saying, but that Publicis had to take the allegations seriously. And so Publicis issued Hart a warning and placed him on disciplinary status, which made Hart ineligible for a bonus.

B. Dinner Program Over a year later, in November 2015, Hart attended a dinner program at which Dr. Terry Dickson presented information about Quillivant. In Dr. Dickson’s presentation, he made 15 separate mistakes, ranging from benign errors like neglecting to “explain Quillivant XR’s proprietary mechanism of release” and misstating which company had developed the medicine, to more concerning errors such as stating that he didn’t “think Quillivant XR is abusable” (this despite the “black box warning” that Quillivant has a “high potential for abuse”). Each time he made a mistake, Hart or his co-worker, Susan Tisch, interrupted the doctor to announce a correction. Hart believed every correction to be legally required under the Food, Drug, and Cosmetic Act (FDCA). It was very unusual to have so many corrections, and because Hart believed “this [wa]s a training issue[,]” he felt obligated to tell Lance Lamotta, Pfizer’s director of training.

The accounts diverge, but here’s what Hart says happened. That night, Hart stepped out of Dr. Dickson’s presentation and called Williams. Hart told him about the large number of corrections and his plan to inform Lamotta. Williams told him not to reach out to Lamotta. Hart alleges that, despite Williams’s instruction, he sent Lamotta an email (and copied Williams on it) saying that he had made a “whole bunch of corrective statements” at the dinner program and that Lamotta could call him for more details. According to Hart, Williams then scheduled a conference

call between himself, Hart, Tisch, and Lamotta, because Williams wanted to hear whatever Hart said to Lamotta. Williams phoned Hart to tell him about the conference call, and Williams also instructed Hart not to tell Lamotta about all 15 corrections because it would put Publicis in a bad light; Hart could tell Lamotta about only a few. Then, just before the conference call was to begin, Hart says that Williams sent him a text message saying, “if you open your mouth and say one word to Pfizer, things are going to get very bad for you.”

Williams denies all of this. He says he didn’t tell Hart not to inform Lamotta about the corrections. And he never sent a threatening text saying that if Hart talked to Lamotta things would get bad for him.

Here’s Hart’s recollection of the conference call. At first Williams did most of the talking, trying to cut off the call by saying that that they didn’t need to waste Lamotta’s time with any specifics. But Lamotta asked to hear from Hart. So, Hart explained that he had made 15 corrections at the dinner program and that Williams had asked him not to tell Lamotta about them. When Hart finished, Lamotta allegedly said he wasn’t concerned about the corrections Hart had made, but he was concerned about the lack of corrections reported by Williams in earlier programs. Curiously, Hart says that Williams texted him, “good job,” after they hung up. But then when Hart and Williams attended a national sales conference in Las Vegas months later, Williams told him “not to talk to anyone from Pfizer”—“[e]specially Lance Lamotta.” According to Hart, this instruction was retaliation for Hart’s telling Lamotta about the corrections.

According to Williams, the conference call described by Hart never happened, and such a call wouldn’t have happened under Publicis’s procedure for handling corrections at speaker programs. He says that Lamotta wouldn’t be involved in corrections made in any individual program, only the legal team would be. Williams also denies instructing Hart not to speak to

anyone from Pfizer at the conference in Las Vegas. As for Lamotta, he says he remembers seeing Williams at sales conferences every year but doesn’t recall any phone conversations with him.

C. Meetings with Dr. Field Almost a year later, in September 2016, Williams asked Hart to get him a meeting with Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Michael Hart v. Publicis Touchpoint Solutions, (6th Cir. 2020).

Michael Hart v. Publicis Touchpoint Solutions (Michael Hart v. Publicis Touchpoint Solutions) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Engquist v. Oregon Department of Agriculture
553 U.S. 591 (Supreme Court, 2008)
Terrence Shaughnessy v. Interpublic Group of Companies
506 F. App'x 369 (Sixth Circuit, 2012)
Kimmelman v. Heather Downs Management Limited
753 N.W.2d 265 (Michigan Court of Appeals, 2008)
Lytle v. Malady
579 N.W.2d 906 (Michigan Supreme Court, 1998)
Suchodolski v. Michigan Consolidated Gas Co.
316 N.W.2d 710 (Michigan Supreme Court, 1982)
Susan Goldfaden v. Wyeth Laboratories, Inc.
482 F. App'x 44 (Sixth Circuit, 2012)
Melissa Brumley v. United Parcel Serv.
909 F.3d 834 (Sixth Circuit, 2018)
Hall v. St. Jude Med. S.C., Inc.
326 F. Supp. 3d 770 (D. Maine, 2018)
Cushman-Lagerstrom v. Citizens Insurance
72 F. App'x 322 (Sixth Circuit, 2003)
Jones-McNamara v. Holzer Health Systems
630 F. App'x 394 (Sixth Circuit, 2015)